Tufts Center for the Study of Drug Development
| Formation | 1976 |
|---|---|
| Founder | Louis Lasagna |
| Type | Think tank |
| Purpose | Researching drug development |
| Location | |
Director | Kenneth I. Kaitin |
| Website |
csdd |
The Tufts Center for the Study of Drug Development is a nonprofit think tank at Tufts University in Boston, dedicated to researching drug development. It was established in 1976 by American physician Louis Lasagna.[1] The Center receives 40% of its funding from the pharmaceutical industry.[2]
Research
The Center has issued numerous studies estimating the cost of developing a new drug: In 2001, researchers from the Center estimated that the cost of doing so was $802 million,[3] and in 2014, they released a study estimating that this amount had risen to nearly $2.6 billion.[2] This study was criticized by Medecins Sans Frontieres, which said it was unreliable because the industry's research and development spending is not made public.[4] Aaron Carroll of the New York Times also criticized the study, saying it "contains a lot of assumptions that tend to favor the pharmaceutical industry."[5]
References
- ↑ History
- 1 2 Silverman, Ed (20 November 2014). "What Does It Cost to Develop a New Drug? Latest Study Says $2.6 Billion". Wall Street Journal. Retrieved 21 November 2014.
- ↑ Pear, Robert (1 December 2001). "Research Cost For New Drugs Said to Soar". New York Times. Retrieved 21 November 2014.
- ↑ Pierson, Ransdell (18 November 2014). "CORRECTED-Tufts says average new drug costs $2.6 bln to develop, critics wary". Reuters. Retrieved 21 November 2014.
- ↑ Carroll, Aaron (19 November 2014). "$2.6 Billion to Develop a Drug? New Estimate Makes Questionable Assumptions". New York Times. Retrieved 25 November 2014.